文献速递骨软组织肉瘤与黑色素瘤

疫情驱动的软组织肉瘤术前中度大分割放疗

Pandemic driven preoperative moderate hypofractionated radiotherapy for soft tissue sarcomas.
PubMed 文献 · Eur J Cancer · 2025-01-13

研究评估新冠疫情期间软组织肉瘤术前中度大分割放疗(从25次2Gy改为14-15次3Gy)的临床结局。66例患者中伤口并发症率33%,2年局部复发累积发生率7.6%,远处转移累积发生率29%,急性3级皮炎1例,晚期3级毒性2例。结论认为该方案未增加术后伤口并发症且局部失败率良好。

要点

  • 66例软组织肉瘤患者接受术前中度大分割放疗,中位随访29个月。
  • 伤口并发症率33%,其中中度13例、重度6例。
  • 2年局部复发累积发生率7.6%,远处转移累积发生率29%。

核心结论

  • 新冠疫情期间术前中度大分割放疗用于软组织肉瘤显示出有希望的结果,未增加术后伤口并发症且局部失败率良好。

研究设计与样本

  • 研究收集2020年1月1日至2023年12月31日期间治疗的患者数据,共分析66例患者,平均年龄74岁(标准差±11)。

主要发现

  • 肿瘤主要位于下肢(64%),平均大小103毫米(标准差±58),中位随访29个月(范围2-50)。
  • 手术患者中77%达到R0切除边缘。
  • 伤口并发症率为33%,其中中度并发症13例、重度6例。
  • 2年局部复发累积发生率为7.6%(标准误3.7%),2年远处转移累积发生率为29%(标准误6%)。
  • 急性3级皮炎发生于1例患者(1.5%),2例患者出现晚期3级毒性(骨折,3.0%);20例患者发生远处转移,其中2例在治疗开始前诊断;18例患者死亡,其中6例死于远处转移,1例死于原发肿瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Moderate hypofractionation was adopted to reduce hospital visits during the COVID-19 pandemic aiming to maintain treatment efficacy for soft tissue sarcoma (STS) patients, shifting preoperative schedules from 25 fractions of 2 Gy to 14-15 fractions of 3 Gy. This study evaluates the clinical implications and outcomes of this schedule, focusing on wound complications, radiation toxicity, local tumour control, and distant metastases. PATIENTS AND METHODS: Data was collected from patients treated between 01 and 01-2020 and 31-12-2023. Outcomes included wound complications within 120 days post-surgery, local-recurrence, distant metastases and radiation toxicity. Logistic regression was performed to identify factors associated with wound complications. The cumulative incidence of local recurrence and distant metastases were estimated with a competing risk model. RESULTS: Sixty-six patients were analysed, with a mean age of 74 years (standard deviation (SD)± 11). Tumours were mainly localized in the lower extremities (64 %), mean size 103 mm (SD±58). Median follow-up was 29 months (range 2-50). A R0 resection margin was achieved in 77 % of the operated patients. The wound complication rate was 33 %, with moderate complications in 13 patients and severe in 6. The cumulative incidences of local recurrence and distant metastases at 2 years were 7.6 % (standard error (SE) 3.7 %) and 29 % (SE 6 %, Fig. 1) respectively. Acute grade 3 dermatitis occurred in one patient (1.5 %)and two patients experienced late grade 3 toxicity (fractures, 3.0 %). Twenty patients developed distant metastases, two diagnosed before start of the treatment. Eighteen patients died, with six deaths from distant metastases and one from the primary tumour. CONCLUSION: Preoperative moderate hypofractionation for STS during COVID-19 showed promising results, with no increase in postoperative wound complications and favourable local failure rates.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Foppele GF, Fiocco M, Ubbels JF, et al. Pandemic driven preoperative moderate hypofractionated radiotherapy for soft tissue sarcomas. Eur J Cancer. 2025. PMID: 39826196. doi:10.1016/j.ejca.2025.115234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。